Barclays plc ADR Stock
Barclays plc ADR Stock
We can see a decrease in the price for Barclays plc ADR. Compared to yesterday it has lost -€0.400 (-1.850%).
Our community identified positive and negative aspects for Barclays plc ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Barclays plc ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Barclays plc ADR in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Barclays plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Barclays plc ADR | -1.850% | -0.935% | -4.505% | 47.222% | -0.935% | 173.548% | 180.795% |
| HSBC Holdings plc ADR | -1.340% | 2.041% | 4.895% | 40.187% | 10.294% | 107.182% | 204.878% |
| Tatton Asset Management | 0.000% | -2.027% | -3.333% | -3.333% | -2.027% | 49.177% | 107.143% |
| NeXR Technologies SE | 0.000% | -7.143% | 116.667% | -50.000% | 160.000% | -99.341% | -99.858% |
Comments
Barclays (NYSE:BCS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for BCS provided by MarketBeat
Barclays (NYSE:BCS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Ratings data for BCS provided by MarketBeat
Barclays (NYSE:BCS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Ratings data for BCS provided by MarketBeat
News
Why NuScale Power Stock Is Powering Down Today
Starting the last week of trading in February on an inauspicious note, NuScale Power (NYSE: SMR) stock is tumbling lower today. With Barclays expressing a more bearish stance on shares of the
